Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This is a prospective randomized controlled, open-labeled study to identify the efficacy of
probucol in combination with valsartan in patients with Diabetes nephropathy. The reduction
of urinary albumin or proteinuria will be the primary outcome studied. The expected study
duration will be 48 weeks.
Phase:
N/A
Details
Lead Sponsor:
Guangdong General Hospital Guangdong Provincial People's Hospital